Adagio Therapeutics wrapped its initial public offering, raising $309.4 million after selling 18.2 million shares at $17 each, right in the middle of its $16 to $18 range.
Shares of ADGI will begin trading later this afternoon, but shares are available for limit orders on Robinhood and other platforms.
Our top picks for where to buy Adagio Therapeutics stock
How to buy Adagio Therapeutics stock
- Choose a stock trading platform. Use our comparison table
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – ADGI. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
Buy Adagio Therapeutics stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Adagio Therapeutics stock price (NYSE: ADGI)
Use our graph to track the performance of ADGI stocks over time.Adagio Therapeutics shares at a glance
Latest market close | $3.48 |
---|---|
52-week range | $0.00 - $0.00 |
50-day moving average | $4.11 |
200-day moving average | $4.65 |
Wall St. target price | $3.83 |
PE ratio | N/A |
Dividend yield | $0 (0%) |
Earnings per share (TTM) | $-2.63 |
Is it a good time to buy Adagio Therapeutics stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Adagio Therapeutics price performance over time
Historical closes compared with the close of $3.48 from 2022-11-14
1 week (2024-07-16) | N/A |
---|---|
1 month (2024-06-23) | N/A |
3 months (2024-04-23) | N/A |
6 months (2024-01-23) | N/A |
1 year (2023-07-23) | N/A |
---|---|
2 years (2022-07-27) | -11.22% |
3 years (2021-07-23) | N/A |
5 years (2019-07-23) | N/A |
Adagio Therapeutics financials
Gross profit TTM | $0 |
---|---|
Return on assets TTM | -37.19% |
Return on equity TTM | -68.48% |
Profit margin | 0% |
Book value | $3.81 |
Market Capitalization | $505 million |
TTM: trailing 12 months
Adagio Therapeutics share dividends
We're not expecting Adagio Therapeutics to pay a dividend over the next 12 months.
You may also wish to consider:
- Sanofi ADR (SNY.US) (3.98% forward annual dividend yield)
Adagio Therapeutics overview
Adagio Therapeutics, Inc. , a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of antibody-based solutions for infectious diseases in the United States. The company's lead product candidate is the ADG20 (adintrevimab), a neutralizing antibody that is in Phase 3 clinical trials for the treatment and prevention of coronavirus disease. Adagio Therapeutics, Inc. has a collaboration agreement with Adimab, LLC for the discovery and optimization of proprietary antibodies; and the Scripps Research Institute to perform research activities to identify vaccine candidates for the prevention, diagnosis or treatment of influenza or beta coronaviruses. The company was incorporated in 2020 and is based in Waltham, Massachusetts. .
Frequently asked questions
nullWhat percentage of Adagio Therapeutics is owned by insiders or institutions?
Currently 32.79% of Adagio Therapeutics shares are held by insiders and 71.591% by institutions. How many people work for Adagio Therapeutics?
Latest data suggests 101 work at Adagio Therapeutics. When does the fiscal year end for Adagio Therapeutics?
Adagio Therapeutics's fiscal year ends in December. Where is Adagio Therapeutics based?
Adagio Therapeutics's address is: 1601 Trapelo Road, Waltham, MA, United States, 02451 What is Adagio Therapeutics's ISIN number?
Adagio Therapeutics's international securities identification number is: US00534A1025 What is Adagio Therapeutics's CUSIP number?
Adagio Therapeutics's Committee on Uniform Securities Identification Procedures number is: 019483106
More guides on Finder
-
Opto review 2024: $0 commission, fractional theme investing
Trade commission-free stocks and ETFs with Opto, and stay ahead by spotting emerging trends through thematic investing.
-
Best paper trading platforms to practice trading with fake money [2024]
Check out our picks of the best paper trading platforms to practice trading and investing with fake money.
-
Put options explained
Learn the basics of put options: what they are, how they work and a few examples.
-
Best broker cash sweep rates for July 2024
Check out our picks for the brokers with the best cash sweep rates on uninvested cash.
-
7 best day trading platforms of July 2024
These are the best day trading platforms, according to Finder’s comprehensive analysis.
-
Today’s best brokerage account bonuses [Signup and transfer promos]
Explore the best bonuses for opening a new brokerage account.
-
11 apps like Webull you need to consider
Looking for a discount broker like Webull that offers something different? Here are some of the top alternatives to consider.
-
How to invest in the S&P 500 in 2024
What you need to know about investing in the leading indicator for the overall US stock market.
-
7 best ways to invest $10K
Check out our 7 ideas for how to invest $10K to maximize your money.
-
5 best ETFs for 2024
Check out the best-performing ETFs so far in 2024.
Ask a question